MOTOR TICS, STEREOTYPIES, AND SELF-FLAGELLATION IN PRIMROSE SYNDROME
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Primrose syndrome consists of cognitive and motor delay, characteristic facial dysmorphism with enlarged and calcified external ears, cataracts, hearing impairment, spastic paraparesis with joint contractures, and distal muscle wasting. To our knowledge, only 5 cases have been reported in the literature.1–5 We report the sixth case and only the second woman to fulfill all clinical elements of Primrose syndrome, who, in addition, manifested motor tics, hand stereotypies, and self-flagellating behaviors. This patient remained undiagnosed for over 4 decades.
Case report.
A 43-year-old woman, the product of a normal vaginal delivery and negative neurologic family history, was born with congenital heart disease (Ebstein malformation, mitral valve prolapse), congenital hip dysplasia, and agenesis of the corpus callosum. In early childhood, she was found to have hearing impairment, cataracts, a nondescript neoplasm of the bone in the palate, ossification of cartilage, cystic changes in bones, diabetes mellitus, and hypothyroidism. Walking began at the age of 6 years. The limited repertoire of her language included “mommy,” “daddy,” “bye-bye,” and “go to school,” before she lost vocalization altogether in her late 30s. She attended special education for about 18 years and worked at putting bakery projects together for several years thereafter. She had been able to run and roller skate before her gait deteriorated. She slowly lost the ability to ambulate independently. At age 35, she started using a walker, and by age 40 needed …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Rituximab Therapy in the Treatment of Juvenile Myasthenia Gravis: The French Experience
Dr. Henry J. Kaminski and Dr. Sarah Wright
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Articles
The Gilles de la Tourette Syndrome–Quality of Life Scale (GTS-QOL)Development and validationA. E. Cavanna, A. Schrag, D. Morley et al.Neurology, October 27, 2008 -
Articles
Objective assessments of longitudinal outcome in Gilles de la Tourette’s syndromeE. J. Pappert, C. G. Goetz, E. D. Louis et al.Neurology, October 13, 2003 -
Resident and Fellow Section
Child Neurology: Diagnosis and treatment of Tourette syndromeMatthew E. Hirschtritt, Marisela E. Dy, Kelly G. Yang et al.Neurology, August 15, 2016 -
Article
Social disinhibition is a heritable subphenotype of tics in Tourette syndromeMatthew E. Hirschtritt, Sabrina M. Darrow, Cornelia Illmann et al.Neurology, July 01, 2016